That’s where pulse oximeters come in. These small devices measure your heart rate and SpO₂. They give you another way to understand how your body responds during exercise and recovery. Also, they may ...

Please provide your email address to receive an email when new articles are posted on . The FDA announced approval of generic Priftin tablets to treat two types of tuberculosis caused by Mycobacterium ...

The U.S. has led the world in several innovations in recent decades: the iPhone, Facebook, and artificial intelligence. But when it comes to sunscreen, Americans have been living in the Dark Ages ...

The Food and Drug Administration has approved the first new sunscreen ingredient for the U.S. market in more than 25 years. The decision announced Tuesday will give Americans access to a ...

Dermatologists say bemotrizinol offers advantages over other compounds in sunscreens currently on the market. By Dani Blum The Food and Drug Administration cleared a new ingredient for sunscreens on ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Retatrutide isn't supposed to be everywhere. Touted as the next generation in the GLP-1 craze, it's an experimental weight-loss drug that is not authorized outside of clinical trials. The Food and ...

The FDA has granted Priority Review to the BLA for atacicept in the treatment of adults with immunoglobulin A nephropathy (IgAN). Atacicept is a recombinant fusion protein that binds to and inhibits ...

May 27 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved AbbVie's (ABBV.N), opens new tab drug to treat blastic plasmacytoid dendritic cell neoplasm (BPDCN), ‌a very rare type of ...

A Daiichi Sankyo and AstraZeneca drug is now approved as a first-line treatment for a particularly difficult-to-treat type of breast cancer, bringing a new targeted therapy to patients that’s ...

The Food and Drug Administration in recent months has approved a small number of drugs quite quickly under a new expedited review program. But Health and Human Services Secretary Robert F. Kennedy Jr.

An official from the US Food and Drug Administration (FDA) on Monday presented three case studies demonstrating how sponsors effectively utilized real-world evidence (RWE) and real-world data (RWD) to ...